Search

Dimitry M Danilenko

from Sedona, AZ
Age ~69
Get Report
Also known as:
Dimitry Dr Danilenko, Dimitry Michael Danilenko, Dimitry W Danilenko, Dimitry M Housley
Phone and address:
35 Woodland Dr, Sedona, AZ 86336
(928) 282-5431
Related to:
Michael Danilenko, 94Katrina Danilenko, 48Katrina Danilenko, 67Misha Danilenko, 31
Connected to:
Anna Y Danilenko, 54Dennis G Danilewicz, 71Galina Danilevsky, 61Jill M Danilewicz, 52William J Danilich, 62Susan C Daniliuk, 70Philippe J Danilo, 60Alexander V Daniloff, 54Elaine M Daniloff, 68Alexander Danilovets, 35

Dimitry Danilenko Phones & Addresses

  • 35 Woodland Dr, Sedona, AZ 86336 (928) 282-5431
  • Santa Rosa Valley, CA
  • 115 Saddle Trl, Westlake Village, CA 91361 (805) 370-0313
  • Thousand Oaks, CA
  • 250 Lewis Ave, Millbrae, CA 94030 (650) 259-0905
  • Foster City, CA
  • Malibu, CA

Work

Company: Danilenko nonclinical drug development Jan 2019 Position: Nonclinical drug development consulting

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of California, Davis 1985 to 1992

Skills

In Vivo • Immunology • Animal Models • Toxicology • Drug Development • Pharmacology • Immunohistochemistry • In Vitro • Drug Discovery • Pathology • Biotechnology • Biopharmaceuticals • Laboratory • Biomarkers • Molecular Biology • Life Sciences • Translational Medicine • Histopathology • Glp • Ind • Biologics • Biology • Translational Research • Monoclonal Antibodies • Toxicologic Pathology • Lifesciences • Inflammation • Dermatopathology

Ranks

Certificate: Diplomate

Industries

Biotechnology

Resumes

Resumes

Dimitry Danilenko Photo 1

Nonclinical Drug Development Consulting

View page
Location:
35 Woodland Dr, Sedona, AZ 86336
Industry:
Biotechnology
Work:
Danilenko Nonclinical Drug Development
Nonclinical Drug Development Consulting
Genentech Jan 2003 - Apr 2018
Principal Scientist-Pathologist and Therapeutic Area Leader at Genentech
Amgen Oct 1992 - Jan 2003
Veterinary Pathologist
Education:
University of California, Davis 1985 - 1992
Doctorates, Doctor of Philosophy University of Minnesota 1981 - 1985
Doctorates, Doctor of Veterinary Medicine, Medicine University of Minnesota 1973 - 1977
Bachelors, Bachelor of Science, Zoology
Skills:
In Vivo
Immunology
Animal Models
Toxicology
Drug Development
Pharmacology
Immunohistochemistry
In Vitro
Drug Discovery
Pathology
Biotechnology
Biopharmaceuticals
Laboratory
Biomarkers
Molecular Biology
Life Sciences
Translational Medicine
Histopathology
Glp
Ind
Biologics
Biology
Translational Research
Monoclonal Antibodies
Toxicologic Pathology
Lifesciences
Inflammation
Dermatopathology
Certifications:
Diplomate
American College of Veterinary Pathologists

Publications

Us Patents

Beta-Like Glycoprotein Hormone Polypeptide And Heterodimer

View page
US Patent:
7358341, Apr 15, 2008
Filed:
May 28, 2003
Appl. No.:
10/448771
Inventors:
Christopher J. R. Paszty - Ventura CA, US
Jin Cao - Tarzana CA, US
Dimitry M. Danilenko - Thousand Oaks CA, US
Jianhua Gong - Thousand Oaks CA, US
David C. Hill - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07K 14/575
C07K 14/59
US Classification:
530397, 530398, 530402, 514 2, 436501, 436500, 435 694
Abstract:
Novel β10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing β10 polypeptides and heterodimeric forms thereof, specifically α2/β10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with β10 polypeptides and α2/β10 heterodimers or their respective binding agents.

Fibroblast Growth Factor-Like Polypeptides

View page
US Patent:
7459540, Dec 2, 2008
Filed:
Aug 23, 2000
Appl. No.:
09/644052
Inventors:
Arlen Thomason - Thousand Oaks CA, US
Benxian Liu - Thousand Oaks CA, US
Dimitry Michael Danilenko - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 39/00
A61K 38/00
US Classification:
530399, 530300, 530350, 4241981
Abstract:
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.

Nucleic Acid Molecules Encoding Beta-Like Glycoprotein Hormone Polypeptides And Heterodimers Thereof

View page
US Patent:
7514239, Apr 7, 2009
Filed:
Mar 27, 2001
Appl. No.:
09/818954
Inventors:
Christopher J. R. Paszty - Ventura CA, US
Jin Cao - Tarzana CA, US
Dimitry M. Danilenko - Thousand Oaks CA, US
Jianhua Gong - Thousand Oaks CA, US
David C. Hill - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07H 21/04
C07K 14/59
US Classification:
435 697, 435 691, 4353201, 4352523, 435325, 536 234, 5303873, 530398, 530397
Abstract:
Novel β10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing β10 polypeptides and heterodimeric forms thereof, specifically α2/β10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with β10 polypeptides and α2/β10 heterodimers or their respective binding agents.

Uses Of Keratinocyte Growth Factor-2

View page
US Patent:
20030144202, Jul 31, 2003
Filed:
Dec 5, 2002
Appl. No.:
10/314372
Inventors:
David Lacey - Newbury Park CA, US
Thomas Ulich - Camarillo CA, US
Dimitry Danilenko - Thousand Oaks CA, US
Catherine Farrell - Agoura CA, US
Assignee:
Amgen Inc.
International Classification:
A61K038/18
US Classification:
514/012000
Abstract:
The present invention concerns the use of a KGF-2 protein(s) as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as in the eye, ear, gums, pancreas, urinary bladder, liver and gastrointestinal tract.

Beta-Like Glycoprotein Hormone Polypeptide And Heterodimer

View page
US Patent:
20030207403, Nov 6, 2003
Filed:
May 28, 2003
Appl. No.:
10/449140
Inventors:
Christopher Paszty - Ventura CA, US
Jin Cao - Tarzana CA, US
Dimitry Danilenko - Thousand Oaks CA, US
Jianhua Gong - Thousand Oaks CA, US
David Hill - Thousand Oaks CA, US
Assignee:
Amgen Inc.
International Classification:
C12P021/02
C12N005/06
C07K014/575
A61K038/24
US Classification:
435/069100, 435/320100, 435/325000, 530/397000, 536/023500, 514/008000
Abstract:
Novel 10 polypeptides and heterodimers thereof, and nucleic acid molecules encoding the same are disclosed. The invention also provides vectors, host cells, selective binding agents, and methods for producing 10 polypeptides and heterodimeric forms thereof, specifically 2/10. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with 10 polypeptides and 2/10 heterodimers or their respective binding agents.

Compositions And Methods For The Treatment Of Diseases And Disorders Associated With Cytokine Signaling

View page
US Patent:
20070212356, Sep 13, 2007
Filed:
Nov 30, 2006
Appl. No.:
11/565395
Inventors:
Yvonne Chen - San Mateo CA, US
Anan Chuntharapai - Colma CA, US
Dimitry Danilenko - Millbrae CA, US
Wenjun Ouyang - Foster City CA, US
Susan Sa - San Francisco CA, US
Patricia Valdez - San Francisco CA, US
Terence Wong - Alameda CA, US
Jianfeng Wu - San Francisco CA, US
Yan Zheng - San Mateo CA, US
International Classification:
A61K 39/395
C07K 16/24
US Classification:
424145100, 530388230
Abstract:
Compositions and methods are provided for the diagnosis and treatment of inflammation and autoimmune disorders, such as psoriasis. Compositions and methods for modulating IL-23 or IL-22 signaling are provided.

Fibroblast Growth Factor-Like Polypeptides

View page
US Patent:
20080071065, Mar 20, 2008
Filed:
Apr 11, 2007
Appl. No.:
11/733769
Inventors:
Arlen Thomason - Thousand Oaks CA, US
Benxian Liu - Thousand Oaks CA, US
Dimitry Danilenko - Thousand Oaks CA, US
Assignee:
AMGEN, INC. - Thousand Oaks CA
International Classification:
C07K 16/46
C07K 14/00
US Classification:
530391100, 530402000
Abstract:
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.

Fibroblast Growth Factor-Like Polypeptides

View page
US Patent:
20080071066, Mar 20, 2008
Filed:
Apr 11, 2007
Appl. No.:
11/733771
Inventors:
Arlen Thomason - Thousand Oaks CA, US
Benxian Liu - Thousand Oaks CA, US
Dimitry Danilenko - Thousand Oaks CA, US
Assignee:
AMGEN, INC. - Thousand Oaks CA
International Classification:
C07K 16/00
US Classification:
530410000, 530402000
Abstract:
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
Control profile
Dimitry M Danilenko from Sedona, AZ, age ~69 Get Report